Rare diseases
Investigational molecules
Locations
Floor 3, Building 9 Accelerator Phase 2, Jiangbei New Area, 210032
Transthera Sciences (Nanjing) Inc. is focused on clinical research in cholangiocarcinoma, with attention to patients whose disease has become refractory or relapsed after prior treatment. The sponsor’s work centers on fibroblast growth factor receptor-altered disease, reflecting interest in a molecularly defined subset of this biliary tract cancer.
The sponsor’s clinical activity is directed toward treatment-resistant disease in a global oncology setting, with research sites across multiple countries supporting access to patients with this rare cancer.
Transthera Sciences (Nanjing) Inc. runs clinical trials in conditions such as Cholangiocarcinoma, among others.
Clinical trials run by this sponsor – those enrolling participants first.
AustriaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
